Doctor profile · Federal record
Dr. Dina Orapallo, CRNP
Acute Care Nurse Practitioner (CMS: Nurse Practitioner) · Philadelphia, PA
- NPI 1154863389
- Accepts Medicare
- 11 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
111 S 11Th St, Suite 6210
Philadelphia, PA 191074824
(215) 503-1021 - Mailing address
-
111 S 11Th Street, Suite 6210
Philadelphia, PA 19107
Credentials & registration
- NPI registered
- November 2016 — 10 yrs on file
- Profile last updated
- January 29, 2019
- Year of graduation
- 2015 — 11 yrs since
- Specialty taxonomy
- 363LA2100X — NUCC code
- State license (1)
- Pennsylvania #SP016373
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1154863389. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
229
Distinct HCPCS
6
Medicare allowed
$17,145
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99232 |
Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | 139 | 60 | $68 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 20 | 16 | $122 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 19 | 18 | $60 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 19 | 18 | $87 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 18 | 17 | $59 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 14 | 13 | $97 |
In context: peer comparison
Among 78 peers in this city , average services per provider: 71. This provider delivers 3.2× the peer median.Open Payments
Industry payments received
All-time total
$390
Transactions
13
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Penumbra, Inc. | 1 | $144.38 | |
| Janssen Pharmaceuticals, Inc | 4 | $80.24 | |
| Novartis Pharmaceuticals Corporation | 5 | $76.37 | |
| Boston Scientific Corporation | 1 | $54.47 | |
| E.R. Squibb & Sons, L.L.C. | 2 | $34.72 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
570
Patients
138
Total drug cost
$431,078
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 359 | 100 | $292,028 |
| Xarelto (Rivaroxaban) | Brand | 167 | 38 | $123,491 |
| Atorvastatin Calcium | Generic | 16 | 0 | $220 |
| Enoxaparin Sodium | Generic | 16 | 0 | $10,087 |
| Savaysa (Edoxaban Tosylate) | Brand | 12 | 0 | $5,252 |
Frequently asked questions
What is Dr. Dina Orapallo's medical specialty?
Dr. Dina Orapallo practices Acute Care Nurse Practitioner in Philadelphia, PA.
Where does Dr. Dina Orapallo practice?
Dr. Dina Orapallo practices at 111 S 11Th St, Philadelphia, PA 191074824. Office phone: 2155031021.
What is Dr. Dina Orapallo's NPI?
Dr. Dina Orapallo's National Provider Identifier (NPI) is 1154863389, issued by NPPES.
Does Dr. Dina Orapallo accept Medicare assignment?
Yes. Dr. Dina Orapallo accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Dina Orapallo commonly perform?
Top Medicare-reported procedures in 2023: Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99213). Source: CMS Medicare Physician & Other Practitioners file.